InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Soparkar Peter, Dirigeant. Director active across 1 companies, notably Adverum Biotechnologies, Inc.. Aggregated, 5 reports have been recorded. Total volume traded: €85k. The latest transaction was disclosed on 19 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
€184175 shares@ €1.05360.2% of flow
Common Stock
SEC:0001209191-22-024977:0·
Ideal exit: 14 Jan 2023 (T+270)
€42,34525,000 shares@ €1.6938100.0% of flow
Common Stock
SEC:0001209191-21-069098·
Ideal exit: 4 Sept 2022 (T+270)
€42,34525,000 shares@ €1.693849.9% of flow
Common Stock
SEC:0001209191-21-069098:0·
Ideal exit: 4 Sept 2022 (T+270)
0220,000 shares0
Common Stock
SEC:0001209191-21-050748·
0220,000 shares0
Common Stock
SEC:0001209191-21-050748:0·
5 of 5 declarations
About Soparkar Peter
Peter Soparkar is an Executive at Adverum Biotechnologies, Inc. In this role, he participates in the strategic direction of the company. Soparkar brings valuable expertise in the sector, thereby contributing to informed decision-making and optimizing Adverum's performance. His commitment to operational excellence is an asset for the company.
